BIB Holdings — ProShares Ultra Nasdaq Biotechnology
Data updated: 2026-08-14
BIB holds 267 securities. The top 10 make up 43.0% of net assets, led by Total Return Swap (7.35%) and ProShares GENIUS Money Market ETF (6.80%). Health Care (69.7%) and Funds & ETFs (8.5%) are the largest sectors, and 79.8% of the portfolio is in United States. No debt holdings are reported.
Holdings cover 89.79% of net asset value (89.11% of total assets; remainder is cash and receivables). As of May 31, 2026 · N-PORT.
BIB Portfolio Holdings
267 holdings of ProShares Ultra Nasdaq Biotechnology by percentage of net assets, from the fund's SEC N-PORT filing as of May 31, 2026. The 100 largest are listed below; the interactive table on this page lists all 267.
| Holding | Ticker | Sector | % of net assets | Value (USD) |
|---|---|---|---|---|
| Total Return Swap | — | Unknown | 7.35% | $5.42M |
| ProShares GENIUS Money Market ETF | — | Funds & ETFs | 6.80% | $5.01M |
| Gilead Sciences, Inc. | GILD | Health Care | 4.66% | $3.43M |
| Vertex Pharmaceuticals, Inc. | VRTX | Health Care | 4.65% | $3.43M |
| Amgen, Inc. | AMGN | Health Care | 4.48% | $3.30M |
| Total Return Swap | — | Unknown | 3.94% | $2.90M |
| Total Return Swap | — | Unknown | 3.26% | $2.40M |
| Regeneron Pharmaceuticals, Inc. | REGN | Health Care | 3.21% | $2.36M |
| Total Return Swap | — | Unknown | 2.62% | $1.93M |
| Alnylam Pharmaceuticals, Inc. | ALNY | Health Care | 2.01% | $1.48M |
| Revolution Medicines, Inc. | RVMD | Health Care | 1.57% | $1.15M |
| Biogen, Inc. | BIIB | Health Care | 1.44% | $1.06M |
| Repurchase Agreement | — | Unknown | 1.28% | $944.61K |
| Illumina, Inc. | ILMN | Health Care | 1.25% | $921.21K |
| United Therapeutics Corp. | UTHR | Health Care | 1.22% | $902.05K |
| Royalty Pharma plc, Class A | RPRX | Health Care | 1.20% | $883.07K |
| Argenx SE | ARGX | Health Care | 1.19% | $877.79K |
| Total Return Swap | — | Unknown | 1.18% | $871.18K |
| Insmed, Inc. | INSM | Health Care | 1.16% | $851.86K |
| Roivant Sciences Ltd. | ROIV | Health Care | 1.08% | $793.54K |
| Incyte Corp. | INCY | Health Care | 0.97% | $711.91K |
| Viatris, Inc. | VTRS | Health Care | 0.94% | $692.11K |
| Moderna, Inc. | MRNA | Health Care | 0.94% | $688.97K |
| Guardant Health, Inc. | GH | Health Care | 0.85% | $629.00K |
| Invesco Government & Agency Portfolio Open-End Fund USD | — | Funds & ETFs | 0.81% | $598.02K |
| Repurchase Agreement | — | Unknown | 0.81% | $594.44K |
| Neurocrine Biosciences, Inc. | NBIX | Health Care | 0.80% | $587.61K |
| Jazz Pharmaceuticals plc | JAZZ | Health Care | 0.73% | $538.01K |
| Ascendis Pharma A/S | ASND | Health Care | 0.69% | $510.07K |
| Summit Therapeutics, Inc. | SMMT | Health Care | 0.68% | $502.77K |
| Exelixis, Inc. | EXEL | Health Care | 0.66% | $484.61K |
| Bridgebio Pharma, Inc. | BBIO | Health Care | 0.64% | $474.89K |
| Medpace Holdings, Inc. | MEDP | Health Care | 0.64% | $469.91K |
| Ionis Pharmaceuticals, Inc. | IONS | Health Care | 0.63% | $467.34K |
| Repurchase Agreement | — | Unknown | 0.61% | $445.83K |
| Axsome Therapeutics, Inc. | AXSM | Health Care | 0.60% | $443.17K |
| Madrigal Pharmaceuticals, Inc. | MDGL | Health Care | 0.57% | $421.19K |
| BioMarin Pharmaceutical, Inc. | BMRN | Health Care | 0.55% | $407.33K |
| BioNTech SE | BNTX | Health Care | 0.55% | $404.24K |
| Arrowhead Pharmaceuticals, Inc. | ARWR | Health Care | 0.55% | $403.42K |
| Sanofi SA | SNY | Health Care | 0.54% | $395.08K |
| Praxis Precision Medicines, Inc. | PRAX | Health Care | 0.49% | $360.12K |
| Cytokinetics, Inc. | CYTK | Health Care | 0.47% | $349.49K |
| BeOne Medicines Ltd. | ONC | Health Care | 0.46% | $340.03K |
| Krystal Biotech, Inc. | KRYS | Health Care | 0.45% | $333.75K |
| Repurchase Agreement | — | Unknown | 0.44% | $326.94K |
| Tempus AI, Inc., Class A | TEM | Information Technology | 0.44% | $324.22K |
| Abivax SA | ABVX | Health Care | 0.41% | $301.20K |
| Nuvalent, Inc., Class A | NUVL | Health Care | 0.41% | $298.60K |
| Halozyme Therapeutics, Inc. | HALO | Health Care | 0.39% | $290.38K |
| ImmunityBio, Inc. | IBRX | Health Care | 0.39% | $285.82K |
| Vaxcyte, Inc. | PCVX | Health Care | 0.37% | $273.50K |
| Alkermes plc | ALKS | Health Care | 0.35% | $260.02K |
| Immunovant, Inc. | IMVT | Health Care | 0.34% | $250.52K |
| Kymera Therapeutics, Inc. | KYMR | Health Care | 0.33% | $245.64K |
| Protagonist Therapeutics, Inc. | PTGX | Health Care | 0.32% | $235.06K |
| Mirum Pharmaceuticals, Inc. | MIRM | Health Care | 0.31% | $226.45K |
| PTC Therapeutics, Inc. | PTCT | Health Care | 0.31% | $226.13K |
| Rhythm Pharmaceuticals, Inc. | RYTM | Health Care | 0.30% | $223.10K |
| Spyre Therapeutics, Inc. | SYRE | Health Care | 0.29% | $213.52K |
| Cogent Biosciences, Inc. | COGT | Health Care | 0.28% | $209.83K |
| CRISPR Therapeutics AG | CRSP | Health Care | 0.27% | $199.44K |
| CG oncology, Inc. | CGON | Health Care | 0.26% | $194.53K |
| Scholar Rock Holding Corp. | SRRK | Health Care | 0.25% | $186.01K |
| Centessa Pharmaceuticals plc | — | Health Care | 0.24% | $175.86K |
| Caris Life Sciences, Inc. | CAI | Health Care | 0.24% | $174.41K |
| Ligand Pharmaceuticals, Inc. | LGND | Health Care | 0.23% | $170.72K |
| Xenon Pharmaceuticals, Inc. | XENE | Health Care | 0.23% | $168.24K |
| Apogee Therapeutics, Inc. | APGE | Health Care | 0.23% | $166.58K |
| Indivior Pharmaceuticals, Inc. | INDV | Health Care | 0.23% | $166.56K |
| Travere Therapeutics, Inc. | TVTX | Health Care | 0.22% | $160.84K |
| Amneal Pharmaceuticals, Inc. | AMRX | Health Care | 0.21% | $153.19K |
| Twist Bioscience Corp. | TWST | Health Care | 0.21% | $151.53K |
| Erasca, Inc. | ERAS | Health Care | 0.20% | $146.94K |
| Newamsterdam Pharma Co. NV | NAMS | Health Care | 0.19% | $143.21K |
| Crinetics Pharmaceuticals, Inc. | CRNX | Health Care | 0.19% | $137.65K |
| ACADIA Pharmaceuticals, Inc. | ACAD | Health Care | 0.19% | $136.52K |
| Veracyte, Inc. | VCYT | Health Care | 0.18% | $136.15K |
| Edgewise Therapeutics, Inc. | EWTX | Health Care | 0.18% | $135.48K |
| Beam Therapeutics, Inc. | BEAM | Health Care | 0.17% | $124.05K |
| Denali Therapeutics, Inc. | DNLI | Health Care | 0.17% | $123.36K |
| 10X Genomics, Inc., Class A | TXG | Health Care | 0.17% | $123.16K |
| Dyne Therapeutics, Inc. | DYN | Health Care | 0.16% | $117.66K |
| Structure Therapeutics, Inc. | GPCR | Health Care | 0.15% | $113.30K |
| Tango Therapeutics, Inc. | TNGX | Health Care | 0.15% | $109.42K |
| Oruka Therapeutics, Inc. | ORKA | Health Care | 0.14% | $104.71K |
| GRAIL, Inc. | GRAL | Health Care | 0.14% | $103.15K |
| Alumis, Inc. | ALMS | Health Care | 0.14% | $100.96K |
| Arcutis Biotherapeutics, Inc. | ARQT | Health Care | 0.13% | $98.44K |
| Disc Medicine, Inc. | IRON | Health Care | 0.13% | $98.16K |
| Supernus Pharmaceuticals, Inc. | SUPN | Health Care | 0.13% | $97.90K |
| Ideaya Biosciences, Inc. | IDYA | Health Care | 0.13% | $95.66K |
| Vera Therapeutics, Inc., Class A | VERA | Health Care | 0.13% | $93.63K |
| Tarsus Pharmaceuticals, Inc. | TARS | Health Care | 0.13% | $93.44K |
| Relay Therapeutics, Inc. | RLAY | Health Care | 0.13% | $92.81K |
| Mineralys Therapeutics, Inc. | MLYS | Health Care | 0.13% | $92.14K |
| Definium Therapeutics, Inc. | DFTX | Health Care | 0.12% | $89.14K |
| Enliven Therapeutics, Inc. | ELVN | Health Care | 0.12% | $86.90K |
| Adaptive Biotechnologies Corp. | ADPT | Health Care | 0.12% | $86.23K |
| Ultragenyx Pharmaceutical, Inc. | RARE | Health Care | 0.12% | $85.49K |
BIB Sector Allocation
ProShares Ultra Nasdaq Biotechnology holdings grouped by sector, by share of the portfolio's market value.
| Sector | Weight | Holdings |
|---|---|---|
| Health Care | 69.7% | 252 |
| Funds & ETFs | 8.5% | 2 |
| Information Technology | 0.5% | 1 |
| Materials | 0.0% | 1 |
| Industrials | 0.0% | 1 |
| Unknown | 21.3% | 10 |
BIB Country Allocation
Where ProShares Ultra Nasdaq Biotechnology's holdings are domiciled, by percentage of net assets (largest 15).
| Country | % of net assets |
|---|---|
| United States | 79.8% |
| United Kingdom | 1.7% |
| Netherlands | 1.6% |
| Ireland | 1.2% |
| Bermuda | 1.1% |
| France | 0.9% |
| Denmark | 0.8% |
| Switzerland | 0.8% |
| Canada | 0.6% |
| Germany | 0.6% |
| Cayman Islands | 0.4% |
| Jersey | 0.1% |
| Israel | 0.1% |
| Luxembourg | 0.1% |
| Singapore | 0.1% |
BIB Portfolio Allocation
Asset-class allocation of ProShares Ultra Nasdaq Biotechnology by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 63.0% |
| Derivatives | 16.0% |
| Other | 6.8% |
| Cash & Equivalents | 4.0% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.